美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读

Interpretation of the second update to the ninth edition of antithrombotic therapy guidelines for venous thromboembolism disease published by American College of Chest Physicians

静脉血栓栓塞症(venous thromboembolism,VTE)主要包括深静脉血栓形成和肺栓塞,VTE作为一种慢性疾病,造成了重大的全球疾病负担。美国胸科医师学会(American College of Chest Physicians,ACCP)第九版VTE抗栓治疗指南(AT9)于2012年发布,并于2016年第一次更新。2021年10月ACCP正式发布了AT9的第二次更新,本次更新就17个VTE相关的临床问题提出了共计29条推荐意见,本文就本次指南更新所提出的推荐意见进行解读。

Venous thromboembolism(VTE), comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that contributes significantly to the global burden of disease. The American College of Chest Physicians(ACCP) published the 9^(th)edition of antithrombotic treatment guidelines for VTE(AT9) in 2012, which was first updated in 2016. In October 2021, ACCP published the 2^(nd)update to AT9, which addressed 17 clinical questions related to VTE and presented 29 guidance statements in total. In this paper we interpreted the recommendations proposed in this update of the guidelines.